Pharmaceutical Company News
- Roche to Stop Antiretroviral Research, Company Says (July 14, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Some Doctors Say No to Drug Company Money (April 15, 2008)
In The New York Times
- Good Step for Generics (January 25, 2008)
Looser patent laws could mean generic version of Tenofovir to come.
In Housing Works AIDS Issues Update, from Housing Works
- Glaxo Withdraws Patent Applications for Abacavir, Trizivir in India (December 10, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Gilead, Royalty Pharma to Pay Emory University $525 Million for Rights to Emtricitabine (July 19, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Who Provides You With Up-to-Date Treatment Information? (December 2004)
A brief review of popular HIV treatment information resources and their reliance on pharmaceutical funding.
In TAGline, from Treatment Action Group
- European Patients Lobby European Commission to Ease Its Ban on Drug Ads (April 30, 2004)
In The Wall Street Journal
- AIDS Healthcare Foundation Asks FDA to Withdraw Approval of GSK's Antiretroviral Drug Trizivir (August 20, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- FDA Orders Gilead for Second Time to Stop Downplaying Risks, Inflating Benefits of Antiretroviral Drug Viread (August 8, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- States, Territories Negotiate $65M in Annual Price Concessions for HIV/AIDS Drugs From Eight Pharmaceutical Companies (August 6, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Global Treatment Update (December 2002)
Gilead strikes a deal with Africa on tenofovir; a new handbook for orgs looking to provide treatment.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Pharmaceutical Giant to Let Generic Company Manufacture Its AIDS Drug (October 15, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention